Open Access
BIO Web Conf.
Volume 65, 2023
EBWFF 2023 - International Scientific Conference Ecological and Biological Well-Being of Flora and Fauna (Part 2)
Article Number 05033
Number of page(s) 6
Section Preventive Healthcare and Urban Ecology
Published online 04 September 2023
  • Bilchenko A.V. Hyperuricemia as a risk factor for cardiovascular morbidity and mortality. Russian Medical Journal. 2009. No. 10. P. 46–48. [Google Scholar]
  • Mychka V.B. et al., Recommendations of experts of the All-Russian Society of Cardiology for the diagnosis and treatment of metabolic syndrome (second revision). 2010. No. 3. P. 15–18. [Google Scholar]
  • Tashkenbayeva E.N. et al., Asymptomatic hyperuricemia, pathogenetic aspects, clinical prediction and correction. Tashkent, FAN, 2014. P. 176. [Google Scholar]
  • Tashkenbayeva E.N., Hyperuricemia in pathogenesis, clinic of the metabolic syndrome and the development of cardiovascular complications: dissertation for the degree. Tashkent, 2010. P. 216 [Google Scholar]
  • Clinical significance of hyperuricemia and uric acid metabolism in the pathology of the cardiovascular system. B.G. Khodzhakuliyev, G.O. Begencheva, D.M. Akhmedova [et al.]. Young scientist. 2014. No. 18. Pp. 178–184 [Google Scholar]
  • Hyperuricemia as a risk factor for target organ damage and the possibility of its drug correction in patients with metabolic syndrome. The topic of the dissertation and abstract on the Higher Attestation Commission of the Russian Federation 14.01.04, Candidate of Sciences Chumachek, Elena Valerievna [Google Scholar]
  • Dubchak, N. New and improved strategies for the treatment of gout. N. Dubchak, G. Falasca. Int J Nephrol Reno vase Dis. 2010. No. 3. P. 145–166. [Google Scholar]
  • Choi HK Independent impact of gout on mortality and risk for coronary heart disease. HK Choi, G. Curhan. Circulation. 2007. No. 116. R. 894–900. [CrossRef] [PubMed] [Google Scholar]
  • ESH/ESC Guidelines for management of arterial hypertension 2013. European Heart Journal. 2013. No. 28. P. 2159–2219. [Google Scholar]
  • Hsu, CY Risk factors for end-stage renal disease: 25-year follow-up. CY Hsu, C. Iribarren, CEMc Culloch, J. Darbinian, ASGo. Arch Intern Med. 2009. No. 4. P. 342–350. [CrossRef] [PubMed] [Google Scholar]
  • Obermayr R. Elevated Uric Acid Increases the Risk for Kidney Disease. R. Obermayr, C. Temml, G. Gutjahr, M. Knechtelsdorfer, R. Oberbauer, R. Klauser-Braun. Am Soc Nephrol. 2008. No. 12. P. 2407–2413. [CrossRef] [PubMed] [Google Scholar]
  • E. Oda, Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. E. Oda, R. Kawai, V. Sukumaran, K. Watanabe. Intern Med. 2009. No. 48. P. 1785–1791. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.